flufenamic acid has been researched along with Liver Neoplasms in 6 studies
Flufenamic Acid: An anthranilic acid derivative with analgesic, anti-inflammatory, and antipyretic properties. It is used in musculoskeletal and joint disorders and administered by mouth and topically. (From Martindale, The Extra Pharmacopoeia, 30th ed, p16)
flufenamic acid : An aromatic amino acid consisting of anthranilic acid carrying an N-(trifluoromethyl)phenyl substituent. An analgesic and anti-inflammatory, it is used in rheumatic disorders.
Liver Neoplasms: Tumors or cancer of the LIVER.
| Excerpt | Relevance | Reference |
|---|---|---|
| " In this study we investigated the induction of apoptosis by 4-aminopyridine (4-AP), a K(+) channel blocker, and its mechanism in HepG2 human hepatoblastoma cells." | 7.70 | Ca2+ influx mediates apoptosis induced by 4-aminopyridine, a K+ channel blocker, in HepG2 human hepatoblastoma cells. ( Jung, MW; Kang, GH; Kang, YS; Kim, JA; Lee, SH; Lee, YS, 2000) |
| "The signaling mechanism of tamoxifen (TAM)-induced apoptosis was investigated in HepG2 human hepatoblastoma cells which do not express the estrogen receptor (ER)." | 7.70 | Involvement of Ca2+ influx in the mechanism of tamoxifen-induced apoptosis in HepG2 human hepatoblastoma cells. ( Jung, MW; Kang, YS; Kim, JA; Lee, SH; Lee, YS, 1999) |
| " In this study we investigated the induction of apoptosis by 4-aminopyridine (4-AP), a K(+) channel blocker, and its mechanism in HepG2 human hepatoblastoma cells." | 3.70 | Ca2+ influx mediates apoptosis induced by 4-aminopyridine, a K+ channel blocker, in HepG2 human hepatoblastoma cells. ( Jung, MW; Kang, GH; Kang, YS; Kim, JA; Lee, SH; Lee, YS, 2000) |
| "The signaling mechanism of tamoxifen (TAM)-induced apoptosis was investigated in HepG2 human hepatoblastoma cells which do not express the estrogen receptor (ER)." | 3.70 | Involvement of Ca2+ influx in the mechanism of tamoxifen-induced apoptosis in HepG2 human hepatoblastoma cells. ( Jung, MW; Kang, YS; Kim, JA; Lee, SH; Lee, YS, 1999) |
| "In rat hepatocytes and HTC hepatoma cells, increases in cell volume stimulate ATP release, and the localized increase in extracellular ATP increases membrane Cl(-) permeability and stimulates cell volume recovery through activation of P(2) receptors." | 1.30 | Evidence for Gd(3+) inhibition of membrane ATP permeability and purinergic signaling. ( Davison, AK; Feranchak, AP; Fitz, JG; Roman, RM; Schwiebert, EM, 1999) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 2 (33.33) | 18.7374 |
| 1990's | 2 (33.33) | 18.2507 |
| 2000's | 1 (16.67) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (16.67) | 2.80 |
| Authors | Studies |
|---|---|
| Li, ZY | 1 |
| Yin, YF | 1 |
| Guo, Y | 1 |
| Li, H | 1 |
| Xu, MQ | 1 |
| Liu, M | 1 |
| Wang, JR | 1 |
| Feng, ZH | 1 |
| Duan, XC | 1 |
| Zhang, S | 1 |
| Zhang, SQ | 1 |
| Wang, GX | 1 |
| Liao, A | 1 |
| Wang, SM | 1 |
| Zhang, X | 1 |
| Roman, RM | 1 |
| Feranchak, AP | 1 |
| Davison, AK | 1 |
| Schwiebert, EM | 1 |
| Fitz, JG | 1 |
| Kim, JA | 2 |
| Kang, YS | 2 |
| Jung, MW | 2 |
| Kang, GH | 1 |
| Lee, SH | 2 |
| Lee, YS | 2 |
| Murray-Lyon, IM | 1 |
| Parsons, VA | 1 |
| Blendis, LM | 1 |
| Dawson, JL | 1 |
| Rake, MO | 1 |
| Laws, JW | 1 |
| Williams, R | 1 |
| Davidova, SY | 1 |
| Shapot, VS | 1 |
| Drozdova, GA | 1 |
6 other studies available for flufenamic acid and Liver Neoplasms
| Article | Year |
|---|---|
Enhancing Anti-Tumor Activity of Sorafenib Mesoporous Silica Nanomatrix in Metastatic Breast Tumor and Hepatocellular Carcinoma via the Co-Administration with Flufenamic Acid.
Topics: 20-Hydroxysteroid Dehydrogenases; Aldo-Keto Reductase Family 1 Member C3; Animals; Anti-Inflammatory | 2020 |
Evidence for Gd(3+) inhibition of membrane ATP permeability and purinergic signaling.
Topics: Adenosine Triphosphate; Animals; Anti-Inflammatory Agents; Anti-Inflammatory Agents, Non-Steroidal; | 1999 |
Ca2+ influx mediates apoptosis induced by 4-aminopyridine, a K+ channel blocker, in HepG2 human hepatoblastoma cells.
Topics: 4-Aminopyridine; Apoptosis; Calcium; Calcium Channel Blockers; Cell Survival; Chelating Agents; DNA | 2000 |
Involvement of Ca2+ influx in the mechanism of tamoxifen-induced apoptosis in HepG2 human hepatoblastoma cells.
Topics: Apoptosis; Calcium; Calcium Channel Blockers; Cell Survival; Chelating Agents; DNA Fragmentation; Do | 1999 |
Treatment of secondary hepatic tumours by ligation of hepatic artery and infusion of cytotoxic drugs.
Topics: Adenocarcinoma; Aged; Angiography; Aortography; Carcinoid Tumor; Chemotherapy, Cancer, Regional Perf | 1970 |
On the heterogeneity of catalase in rat liver and experimental hepatomas of rats and mice.
Topics: Alcohols; Animals; Bile Acids and Salts; Carcinoma, Hepatocellular; Catalase; Cell Membrane; Female; | 1970 |